T. Rowe Price Associates’s ATRenew RERE Stock Holding History

T. Rowe Price Associates’s Portfolio RERE Stock Details RERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.8M	Buy	5,121,851 +937,897	+22%	+$4.16M	﹤0.01%	1150
2026 Q1	$19.6M	Buy	4,183,954 +326,270	+8%	+$1.84M	﹤0.01%	1042
2025 Q4	$20.4M	Buy	3,857,684 +1,450,764	+60%	+$6.5M	﹤0.01%	1054
2025 Q3	$11.1M	Buy	2,406,920 +201,687	+9%	+$812K	﹤0.01%	1202
2025 Q2	$7.3M	Sell	2,205,233 -33,801	-2%	-$87.9K	﹤0.01%	1187
2025 Q1	$6.58M	Sell	2,239,034 -60,373	-3%	-$177K	﹤0.01%	1198
2024 Q4	$6.62M	Buy	+2,299,407	New	+$6.4M	﹤0.01%	1217

Other funds holding RERE

Tiger Global Management New York $24B AUM 39.59% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

YCM

Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

TPC

Tiger Pacific Capital New York $218M AUM 12.12% 1-Year Est. Return

T. Rowe Price Associates's RERE Position: Q2 2026 in Review

T. Rowe Price Associates increased its ATRenew (RERE) stake by 22% in Q2 2026, buying an estimated $4.16M and bringing the position to 5,121,851 shares worth $19.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1150.

T. Rowe Price Associates first reported a position in RERE in Q4 2024 and has held it in 7 quarters since. The position peaked at $20.4M in Q4 2025. 75 funds tracked by Wall St. Rank hold RERE as of Q2 2026.

T. Rowe Price Associates held 5,121,851 shares of ATRenew worth $19.8M as of Q2 2026.
T. Rowe Price Associates bought 937,897 ATRenew shares in Q2 2026, an estimated $4.16M.
ATRenew made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1150 holding.
T. Rowe Price Associates first reported a position in ATRenew in Q4 2024 and has held it in 7 quarters since.
T. Rowe Price Associates's ATRenew position peaked at $20.4M in Q4 2025.
75 funds tracked by Wall St. Rank held ATRenew as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.